PER = 8.1 PEG = 0.6 FORECAST EPS GROWTH = 16% ROCE = 11%
The pension contributions are reducing. Schroder's now holding 15%.; Wellcome Trust on 4%. Recent (24 Jan) update disappointed, with operating profit failing to meet expectations by 15%, but the company remains profitable with limited debt. You can now buy at less than the fundraising price of 110p of July 2020. Seems cheap to me.
It totally depends on the market! We will have to wait until the US markets open to see exactly what will happen today. My guess is that we will see the week out slightly down on today, but perhaps not enough to nullify the dividend. Thanks JPM!
Trading update - comfortably ahead15 Mar 2022 07:09
"... the Board now expects full year underlying profit before tax for the year ended 30 April 2022 to be in the region of £150m, comfortably ahead of consensus[1] of £133.9m. The Board expects disposal profits to account for c.33% of the full year underlying profit before tax compared to c.43% in the prior year."
"What negative is there?" ..."It appears however, that 2022 cash generation targets have been lowered slightly to £1.3bn-£1.4bn." So a wee bit of bad news, but this should see the day out at c635. Nice dividend news.
Nice read across from FCAP, where the revenues will exceed the top end estimates? There are going to many mergers, acquisitions and fund raisings to keep these chaps busy.
Talking to an empty room here, but for info RAT is currently on: PER = 9 PEG = 0.7 YIELD = 5.4% FORECAST EPS = +15% There are forecasts for greater expenditure on IT systems, but this is manageable out of current cash. GARP and income compatible?
A few institutional holders have sold up, presumably because they now see better opportunities elsewhere in this falling market. No other news may be good news, but I am not brave enough to add here!